1. Home
  2. CALC vs BAOS Comparison

CALC vs BAOS Comparison

Compare CALC & BAOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CalciMedica Inc.

CALC

CalciMedica Inc.

HOLD

Current Price

$1.08

Market Cap

7.6M

Sector

Health Care

ML Signal

HOLD

Logo Baosheng Media Group Holdings

BAOS

Baosheng Media Group Holdings

BUY

Current Price

$0.17

Market Cap

9.1M

ML Signal

BUY

Company Overview

Basic Information
Metric
CALC
BAOS
Founded
2011
2018
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Business Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
7.6M
9.1M
IPO Year
2020
2020

Fundamental Metrics

Financial Performance
Metric
CALC
BAOS
Price
$1.08
$0.17
Analyst Decision
Buy
Analyst Count
4
0
Target Price
★ $38.00
N/A
AVG Volume (30 Days)
56.0K
★ 254.6K
Earning Date
11-11-2026
11-27-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.44
$0.16
52 Week High
$72.00
$3.82

Technical Indicators

Market Signals
Indicator
CALC
BAOS
Relative Strength Index (RSI) 23.53 24.12
Support Level $0.44 N/A
Resistance Level $2.31 $0.26
Average True Range (ATR) 0.12 0.02
MACD 0.05 0.01
Stochastic Oscillator 0.00 14.17

Price Performance

Historical Comparison
CALC
BAOS

About CALC CalciMedica Inc.

CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapeutics that treat serious illnesses driven by inflammatory and immunologic processes and direct cellular damage. Its product candidates act upon calcium release-activated calcium (CRAC) channels and would constitute a new class of drugs. Its product candidate is Auxora, a potent and selective intravenous formulated small molecule CRAC channel inhibitor containing the active compound zegocractin (formerly referred to as CM4620) that, in animal models, reduced acute epithelial and/or endothelial cell injury and inflammation in organs, such as the pancreas, lungs and kidneys. The company operates as one operating segment focused on developing and commercializing therapeutics in the U.S.

About BAOS Baosheng Media Group Holdings

Baosheng Media Group Holdings Ltd is a China-based online marketing solution provider. The company provides internet marketing, short-video and V-log marketing, content production and operation, e-commerce marketing, data platform services, and AI technology-related services. It also offers customized marketing solutions and channel marketing services through partnerships with internet platforms such as Tencent, Alibaba, ByteDance, and Kuaishou.

Share on Social Networks: